MONTREAL--(BUSINESS WIRE)--March 24, 2004--Viropro, Inc. announced today that Trivor Financial Group I LP has committed to invest at least $1M US incrementally over the next several weeks to facilitate growth of Viropro’s target acquisitions in the international Life Sciences sector. Trivor is also committed to working with Viropro as a lead funder for these and other acquisitions being contemplated.
The Trivor Financial Group I LP is a Montreal-based private equity investment partnership establishing an investment portfolio of emerging companies with capital requirements and high growth potential in Healthcare and Biotechnology.
Viropro’s two initial acquisitions are expected to propel the company into revenue during 2004. One is a provider of products and services with an installed base in the Healthcare market. The other is a Biotech company with major agreements between partners in Canada, the US and Brazil involving both the purchase of licensed products for sale into Brazil (and possible technology transfer) and the licensing of products from Brazil for sales into North America.
An agreement with another key investor is close to being finalized for investment into this Biotech initiative. Potential for this business, starting with major agreements, is substantial, with revenues expected to start during latter-part 2004.
About Viropro, Inc.
Viropro, Inc. (VPRO: OTCBB) is an emerging provider of management, product and technology solutions for international Life Sciences markets. The Company is seeking to establish a growth portfolio in Life Sciences through revenue-producing acquisitions with the potential for continued shareholder value. Through its growth, the Company also aims to facilitate the discovery and development of chemical and biological products and processes that will benefit medical science and increase the quality of life.
Viropro, Inc’s Safe Harbor Statement
Except for any historic information contained herein, the matters discussed in this press release contain forward-looking statements that involve risks and uncertainties, which are subject to section 27A of the Securities Act of 1933 and section 21E of the Exchange Act of 1934, and are subject to safe harbor created by these sections. Any statements that express or involve discussions with respect to predictions, beliefs, plans, projections, objectives, goals, assumptions of future events or performances are not statements of historical fact and may be “forward looking statements”. Forward looking statements in this release may be identified through the use of such words as “expects”, “anticipates”, “estimates”, “believes”, or statements indicating certain actions “may”, “could”, or “might” occur. Actual results, performance or achievements could differ materially from those anticipated in such forward-looking statements, which involve numerous risks and uncertainties, including the Company’s ability to market its products and services in a competitive environment as well as other factors.
Contacts
Trivor Financial Communications Jerome Cliche, 514-876-1801 jcliche@trivor-inc.com